Two developments in the Spring of 2016 have focused on abortion and Down syndrome prenatal testing. Continue Reading
April 14, 2016
Response to Art Caplan: provide ALL the recommended information with prenatal testing for Down syndrome
The headline for Art Caplan’s March column for Medscape asked “Disclosing Down syndrome to pregnant patients: must you give an upside?” In it, Caplan raises concerns about recent legislative efforts concerning delivering test results for Down syndrome. His concerns, however, are not based on what those laws actually require. Continue Reading
March 31, 2016
Eugenics: then and now in the era of prenatal testing for Down syndrome
Is prenatal testing for Down syndrome eugenics? Let's compare how eugenics programs were justified in the past with how prenatal testing is currently administered. Continue Reading
March 24, 2016
Indiana bans Down syndrome selective abortions
Well ... not exactly. Read to the end to see what the law says, what it actually does, and the problem that it codifies about Down syndrome. Continue Reading
March 4, 2016
Abortion, the Supreme Court, & Down syndrome
Wednesday, March 2, 2016, the United Supreme Court heard arguments on the first major abortion case before it in years. It reveals what is at issue with the vacancy on the court due to Justice Scalia's death and the option most women choose following a prenatal diagnosis of Down syndrome: abortion. Continue Reading
January 14, 2016
Ohio’s Down Syndrome Fact Sheet: Revision Needed
At the end of 2014, Ohio joined the states in passing the Down Syndrome Information Act (DSIA). Almost a year later, its Department of Health has issued the fact sheet to be provided all patients. Let's take a look at it. Continue Reading
January 5, 2016
Obstetricians’ 2016 Resolutions for Prenatal Genetic Testing
With the start of 2016, obstetricians, like everyone else, are making their New Year's resolutions. Here are their resolutions for counseling their patients about prenatal genetic testing. Continue Reading
December 14, 2015
Will the FDA regulate Sequenom (and other cfDNA labs)?
Sequenom launched its MaterniT21 cell free DNA screen on the marketplace in October 2011. Four years later, screens like Sequenom's remain largely unregulated. The FDA is moving to change that. Continue Reading
December 4, 2015
The ABLE Act: changing the cost of a life with Down syndrome
Since the House of Representatives passed the ABLE Act in December 2014, it has gone on to be enacted into law with dozens of states already enacting enabling legislation for the ABLE savings accounts and the Treasury Department finalizing regulations for these accounts. A thought occurred on the impact these savings accounts will also have on prenatal genetic testing. Continue Reading
Recent Comments